Aim: We reviewed our experience in redo valvular surgery to evaluate trends in shortand long-term outcomes.
| INTRODUCTION
There is a trend toward an increase in the number of older patients who undergo redo valvular surgery. The mortality rate following redo valvular surgery may exceed 7.0%. 1, 2 In our previous report describing outcomes of redo valvular surgery, the mortality rate was 6.7% and was greater than 7.0% in patients older than 75 years. 3, 4 (10.8%) were third redos, and 16 were fourth redos (2.9%). Overall, 555 redo valvular surgeries were performed in the past 25 years.
The mean follow-up period was 6.8 ± 6.3 years (range, 0.04-25.7 years) and the rate of follow-up was 98.7%.
| Surgical techniques
In a third of the patients, extracorporeal circulation was established with peripheral cannulation prior to resternotomy to prevent great vessel or cardiac injury in cases where the right ventricle was close to the sternum as seen on computed tomography. During this time period, we did not perform minimally invasive surgery for redo cases.
Myocardial protection consisted of antegrade or retrograde cold blood cardioplegia or a combination of antegrade/retrograde cardioplegia.
The majority of patients underwent ascending aortic cannulation. In the presence of multiple previous ascending aortic cannulation, the femoral artery was used. We attempted to isolate and clamp a patent internal mammary artery graft whenever possible. 
| Statistical analysis

| Previous surgery (Table 2)
In the aortic position, almost all of the patients received valve replacement using either biological (n = 56) or mechanical (n = 78) 
| Causes of redo surgery (Table 3)
The most common cause of redo valvular surgery was structural valve deterioration in the aortic (n = 51) and mitral (n = 219) positions. In the tricuspid position, structural valve deterioration occurred in 48 patients, while newly developed tricuspid regurgitation occurred in 133 patients. Mechanical valve thrombosis in the aortic position occurred in eight patients. Emergency surgery was required in four patients and the mortality was 37.5% (3/8). Table 4 summarizes the types of prostheses that were used in the present surgical procedures.
| Present redo surgery
The interval between previous and present surgery was 11.8 ± 8.0
years. At redo surgery, we experienced re-entry injuries to the ascending aorta (n = 4), innominate vein (n = 13), or right ventricle (n = 15). Peripheral extracorporeal circulation allowed us to successfully manage these injuries, so that there were no mortalities from reentry injuries.
In the aortic position, a valve repair was performed in eight (8.0%) patients, and in the mitral position, it was performed in 59 (18.8%) patients. In the aortic and mitral positions, mechanical and bioprosthetic valves were each implanted in half of the patients. Sixty-two patients who had a history of mitral valve repair underwent mitral valve replacement (n = 44) and redo mitral repair (n = 18). Tricuspid valve repair was performed in 91% of the patients. 
| Early outcomes
The overall rate of hospital death was 5.8% (32/555 redo procedures) and the 30-day mortality was 3.0% (17/555 redo procedures). The causes of hospital death included multi-organ failure (n = 12), low output syndrome (n = 5), arrhythmia (n = 4), uncontrollable bleeding (n = 4), perioperative myocardial infarction (n = 2), liver failure (n = 1), renal failure (n = 1), sepsis caused by methicillin-resistant Staphylococcus aureus (n = 1), and cerebral hemorrhage (n = 1).
Hospital mortality based on the patients' age was 3.6% at the age of <61 years, 5.5% from 61 to 69 years, 7.3% from 70 to 79 years, and 13.3% at the age older than 80 years. The mortality in patients aged 69 years and below was 4.5% and that aged 70 years and above was 8.3% (P = 0.0722).
Hospital death based on the number of redo surgeries was first redo, 7.3%; second redo, 3.9%; third redo, 3.2%; and fourth redo, 6.2%.
Hospital death was analyzed based on the operative techniques irrespective of reoperative causes. The rate of hospital death in mitral valve replacement after aortic valve replacement (AVR) (n = 5) was much higher (12.5%). Hospital mortality rate following redo double valve replacement in patients with a history of double valve replacement was 7.7%.
Risk factors for hospital mortality by multivariate regression analysis were pre-operative NYHA class III/IV (P = 0.0007, odds ratio = 4.403, 95% confidence interval: 1.875-10.339) and hemodialysis (P = 0.0383, odds ratio = 7.196, 95% confidence interval: 1.112-46.557). Patients' age was not a risk factor for hospital death (P = 0.1641).
The main post-operative morbidities were reexploration for bleeding (n = 27; 4.9%), pacemaker implantation (n = 20; 3.6%), pneumonia (n = 12; 2.2%), mediastinitis (n = 5; 0.9%), cerebral infarction with neurological deficits (n = 5; 0.9%), heart failure (n = 5; 0.9%),
intestinal bleeding (n = 3; 0.5%), tracheostomy (n = 3; 0.5%), and newly required hemodialysis (n = 3; 0.5%) ( Table 5 ). A survival curve based on pre-operative NYHA class is shown in Figure 3A . There was a significant difference in survival rate between NYHA classes I/II and III/IV (65.6% ± 5.7% vs 61.2% ± 6.6% at 15 years, log-rank test, P = 0.0419).
The survival rate based on the number of redo surgeries is shown in Figure 3B . There was also a significant difference in survival rate between first-time redo surgeries and second and more redo surgeries (67.0% ± 5.1% vs 58.0% ± 8.0% at 15 years, log-rank test, P = 0.0189).
| Freedom from valve-related events
Freedom rates from valve-related events at 15 and 20 years were 59.8% ± 4.5% and 49.5% ± 5.4%, respectively.
| Freedom from cardiac death
Freedom rates from cardiac death at 15 and 20 years were 69.6% ± 4.4% and 65.2% ± 5.1%, respectively. Freedom rates from cardiac death based on the four age groups (<61, 61-69, 70-79, and 80 years or older) are shown in Figure 4 (log-rank test, P < 0.0001). 
| DISCUSSION
FIGURE 3
Survival curves based on pre-operative NYHA class (A) and the number of redo surgeries (B). There was a significant difference in survival rate between NYHA classes I/II and III/IV (65.6% ± 5.7% vs 61.2% ± 6.6% at 15 years, log-rank test, P = 0.0419). There was also a significant difference in survival rate between the first time of redo surgery and second and more redo surgeries (67.0% ± 5.1% vs 58.0% ± 8.0% at 15 years, log-rank test, P = 0.0189 chronic obstructive pulmonary disease, 23 renal failure, 18 and peripheral vascular disease. 20, 23 Early referral in older patients with NYHA class I/II may help to decrease hospital mortality in these higher risk patients. 16 In addition, hospital mortality may be decreased by the use of pre-operative computed tomography scans and the use of specially designed sternal retractors to help decrease injuries incurred during sternal re-entry. 25, 26 The use of multidimensional imaging models may also help to facilitate the surgical procedure. The present study is limited in that this was a retrospective analysis of redo valvular surgery over the past 25 years. During this period, the durability of bioprostheses, and pre-/post-operative management of patients have changed.
In conclusion, although the number of redo valvular surgeries has increased, particularly in the older group, the hospital mortality rate has improved. Early referral (NYHA class I or II) for redo surgery, especially in older patients, may help to improve early and late outcomes.
